We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Piper Sandler analyst David Westenberg raised the firm’s price target on Labcorp (LH) to $240 from $235 following quarterly results. The firm remains on the sidelines with a Neutral rating on ...

Barclays analyst Stephanie Davis raised the firm’s price target on Labcorp (LH) to $249 from $234 and keeps an Equal Weight rating on the shares post the Q3 report. The firm says Labcorp could ...

Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens.

Oct 24 (Reuters) - Laboratory operator Labcorp (LH.N), opens new tab beat Wall Street estimates for third-quarter profit and revenue on Thursday as strong demand for diagnostic tests offset a hit ...

Baird raised the firm’s price target on Labcorp (LH) to $289 from $282 and keeps an Outperform rating on the shares. The firm said they posted a strong quarterly update on Diagnostic strength ...

chairman and CEO of Labcorp. “Our results demonstrate momentum in our core businesses as we introduced new tests, and extended our leadership position in specialty testing. We announced or ...

LabCorp (NYSE:LH) coverage was initiated at ... The investment firm set its price target for the stock at $235.

Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C., Oct 10, 2024 /PRNewswire ...

for distribution of its First To Know syphilis test in the U.S. The test provides results in 15 minutes with as little as a single drop of blood. The test will be available to hospitals and clinicians ...